The FDA said today that it will hold an advisory meeting on November 6 and November 7, 2019, to discuss the role of ethylene oxide (EO) sterilization of medical devices in public health, as well as the risks of the sterilization process.
The general hospital and personal use devices panel of the FDA’s medical devices advisory committee will conduct the meeting to help the agency provide advice and make recommendations on the use of the carcinogenic sterilant gas.